Retrospective Analysis of Rechallenge with Ipilimumab in Patients with Metastatic Melanoma

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td class="align_left">BRAF mutation</td><td class="align_center">Number of cases (%)</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td class="align_left">Present</td><td class="align_center">6 (27)</td></tr><tr><td class="align_left">Absent</td><td class="align_center">12 (54)</td></tr><tr><td class="align_left">Unknown</td><td class="align_center">4 (18)</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Journal of Skin Cancer

tab2

Table 2

Table 2: Retrospective Analysis of Rechallenge with Ipilimumab in Patients with Metastatic Melanoma 